Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
Is a |
proguanilhydrochlorid + chloroquinphosphat |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chloroquine (substance) |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Proguanil hydrochloride (substance) |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Biguanide (substance) |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
Is a |
Proguanil hydrochloride 100 mg oral tablet |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Proguanil |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
Has manufactured dose form |
Oral tablet |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Proguanil hydrochloride (substance) |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
Is a |
Product containing chloroquine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chloroquine phosphate |
false |
Inferred relationship |
Some |
|
|
proguanilhydrochlorid 100 mg tablet og chloroquinphosphat 250 mg tablet, pakke |
Is a |
Proguanil-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|